Award
National Institute of Biomedical Imaging and Bioengineering 1R01EB037010-01A1
Development of a multifunctional interventional device for biopsy and optical imaging-based phase-0 drug response measurements
Recipient
Brigham and Women's Hospital
Award Amount
$749,901.00
Ceiling
$749,901.00
Awarded
April 28, 2026
Identifier
1R01EB037010-01A1
This award funds the development of a minimally invasive interventional device for rapid drug testing and optical imaging to measure drug response in cancer patients, aiming to enhance drug development efficiency and personalized medicine.
Description
Developing a device that can test multiple drugs rapidly and directly in individual patients without systemic toxicity via a short low-risk outpatient procedure to improve drug development and personalized treatment selection.